Latest Stock Buy or Sell? Make More Informed Decisions!

Market. Small caps are generally more volatile because their earnings are not as diversified as a bigger company, and there is a lot less volume and institutional coverage. He is launching a Cannabis open-ended fund. Some of the technical signals he looks at are showing the sector has bottomed and will start to move up. There is a scarcity of Marijuana stocks globally, even if not in Canada. The next catalyst could be global investors.

They have a great product. Their orders tend to be lumpy. The US is probably going to ramp up later this year or next and then orders will get bigger. They had some production issues but they have figured all that out before going into the US. Management has large holdings. (Analysts’ target: $2.50).

Their numbers are fantastic from a yield point of view. They are US operators but listed in Canada. They just built a second facility. They are already one of the biggest players there. They just acquired a company that does extract product in California. Following this the PE will be less than 9 times.

It has been drifting over the last three or four months. They will just move into sales this year. They continue to execute. He thinks you will see a fair amount of news flow later this year. The cellular networks are quite excited by their product. He thinks there is lots of future and the story really hasn’t developed yet.

They are building an integrated device allowing for two way talk within fleets. It has taken time for them to get all the certifications and approvals to get here. There were concerns that are now behind them. We need to see sales start to transpire into fleets in the US.

Over the last 12 to 24 months has had a number of reimbursement cuts or rumours of them. It is now trading at a cheap valuation. Assuming no more cuts, then they should be starting to build on that. In recent earnings surgical centers were stronger than analysts expected. They have a new product to roll out the second half of this year. It is an at-home dispensing product. It'll be a 2019 story in terms of the uptick.

They were one of the first rec licenses because they were one of the first med licenses. They tend to sell out in all dispensaries they go into. They took over a facility next to them and so are increasing production. They are also building a new building right now.

(A Top Pick Jun 22/17, Down 70.80%) You got a 1/10^th of a VMD-X share for every PHM-X share you owned, and this increase the return on this pick. He only held onto the VMD-X shares.

(A Top Pick Jun 22/17, Down 51%) They haven't executed as well as the street would have liked. He thinks it is fairly cheap right now. They have not had the deliveries that people expected and most people expected they would have more US sales by now.

(A Top Pick Jun 22/17, Down 32%) They have an interesting business. After their merger, they are continuing to grow the two companies. He thinks this one is going to do well. He is looking at buying it again.

It is probably the top performing energy stock over a two year period. We are now starting to see quite an upturn in the commodity prices. He would continue to hold it if he did.

WEED-T vs. ACB-T. He would pick WEED-T. They are probably building a more sustainable diverse company.

WEED-T vs. ACB-T. He would pick WEED-T. They are probably building a more sustainable diverse company.

He has been watching it because they are making a lot of acquisitions. Their base technology is from Hops and Barley.

They have made acquisitions around the world. They are trying to build a global cannabis company. We need to see some execution from management and some cash flow from all these investments.